Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine as an Adjuvant to Norepinephrine in Weaning Critically Ill Patients From Vasopressors
NCT06930235Completed
- Sponsor
- Sohag University
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of midodrine in hypotension and Shock (2 arms), sponsored by Sohag University. Primary endpoint: Follow up of critically ill patients on vasopressors at 48 hours. Started Mar 2025; status: completed.
02
Drugs
midodrine
03
Conditions
hypotensionShock
Beyond the preview
Go deeper on NCT06930235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06930235.